Sanchez Ramiro — SEC Form 4 filings
SEC reporting owner CIK 1830326. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-10.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-01-23 to 2026-06-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | Director | 3 | — | — | 4 |
| Cerevel Therapeutics Holdings, Inc. (CERE) | Chief Medical Officer | 2 | — | — | 4 |
| Rapport Therapeutics, Inc. (RAPP) | Director | 3 | — | — | 3 |
Form 4 filings — Sanchez Ramiro
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-10 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 15,200 (derivative) @ $0 | EDGAR |
| 2026-05-14 | 4 | Alto Neuroscience, Inc. (ANRO) | Grant/award (A): 10,958 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Alto Neuroscience, Inc. (ANRO) | Grant/award (A): 3,806 (derivative) @ $11.82 | EDGAR |
| 2025-08-14 | 4 | Alto Neuroscience, Inc. (ANRO) | Grant/award (A): 30,574 (derivative) @ $0 · Grant/award (A): 3,928 (derivative) @ $2.21 | EDGAR |
| 2025-06-18 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 10,925 (derivative) @ $0 | EDGAR |
| 2024-11-07 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 29,756 (derivative) @ $0 | EDGAR |
| 2024-08-05 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Disposition to issuer (D): 14,673 · Disposition to issuer (D): 1,393,153 (derivative) · Disposition to issuer (D): 87,573 (derivative) @ $0 | EDGAR |
| 2024-01-23 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Grant/award (A): 87,573 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1830326 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →